Back to top

Analyst Blog

Specialty chemical company Albermale Corporation (ALB - Snapshot Report) announced the opening of a new Research and Operations Center (ROC) in its Yeosu facility in South Korea. The facility currently manufactures lab-scale and pilot-scale quantities of single site catalysts and components used in the polymer industry by deploying the company’s ActivCat and Advantage technologies

The state-of-the-art ROC will boast new analytical and polymerization labs to conduct research on the single site catalysts and components used in the polymer industry and enhance production. The ROC will also ensure faster development of new catalysts and considerably reduce time-to-market for the products. Moreover, the ROC is expected to create more businesses throughout Asia Pacific for Albemarle's commercial plant slated to be operational at the Yeosu site by late 2012.

The company’s board also approved an expansion program at the Yeosu facility to produce Albemarle's PureGrowth products. The expansion is expected to be completed in 2013. The products are used in metal organic chemical vapor deposition (MOCVD), a process used to manufacture chips for semiconductors, LEDs, and optoelectronic devices.

Albemarle Corporation, is a leading global developer, manufacturer and marketer of highly engineered specialty chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, automotive/transportation, pharmaceuticals, crop protection, food-safety and custom chemistry services.

Last month, Albermale released its second quarter 2012 results. The company’s earnings (excluding one-time charges) came in at $1.24 per share exceeding the Zacks Consensus Estimate by a penny. After including one-time charges of 82 cents per share, earnings came in at 42 cents compared with $1.23 in the year-ago quarter. Revenue for the quarter plunged 7.7% to $684.9 million compared with $742.1 million in the second quarter of 2011.

The company, which competes with Chemtura Corporation (CHMT - Snapshot Report) maintains a Zacks #3 Rank, which translates into a short-term (1 to 3 months) Hold rating. We currently have a long-term Neutral recommendation on the shares of Albermale.

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ERBA DIAGNO… ERB 3.00 +3.09%
SANCHEZ ENE… SN 34.18 +2.67%
THE PANTRY… PTRY 21.02 +2.09%
INTEL CP INTC 35.15 +1.88%
CLAYTON WIL… CWEI 117.30 +1.78%